EMMA Insider Trading Activity and SEC Form 4 Filings
EMMA insider trading summary
Over the past 12 months, insiders at Emmaus Life Sciences, Inc. (EMMA) reported 4 open-market purchases worth $15K by 1 insider and no sales on SEC Form 4. Net insider buying was $15K.
Latest EMMA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Willis C Lee | CEO | Buy | $5K (100,000 @ $0.05) |
| Aug 28, 2026 | Willis C Lee | CEO | Buy | $6K (94,767 @ $0.06) |
| Aug 27, 2026 | Willis C Lee | CEO | Buy | $3K (50,000 @ $0.05) |
| Aug 25, 2026 | Willis C Lee | CEO | Buy | $2K (46,000 @ $0.04) |
| Aug 29, 2025 | Willis C Lee | CEO | Buy | $2K (170,000 @ $0.01) |
| May 30, 2025 | Willis C Lee | CEO | Buy | $1K (70,000 @ $0.02) |
| Sep 16, 2024 | Seah H. Lim | Insider | Buy | $800 (20,000 @ $0.04) |
| Feb 29, 2024 | Willis C Lee | Co-President & COO | Buy | $10K (77,000 @ $0.13) |
| Feb 28, 2024 | Willis C Lee | Co-President & COO | Buy | $2K (15,000 @ $0.12) |
| Feb 27, 2024 | Willis C Lee | Co-President & COO | Buy | $1K (10,000 @ $0.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.